Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data by Müzeyyen Aslaner Ak, Ayfer Gedük, İbrahim Halil Açar, Merve Gökçen Polat, Cenk Sunu, Ali Zahit Bolaman, Tuba Hacıbekiroğlu, Birol Güvenç, Şehmus Ertop

Get full text

Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients by Sinan Mersin, Ayfer Gedük, Özgür Mehtap, Pınar Tarkun, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün, Emel Merve Yenihayat, Hayrunnisa Albayrak, Abdullah Hacıhanefioğlu

Get full text

THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY by Müzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk, Mehmet Ali Uçar, Hacer Kale, Tugba Hacibekiroglu, Merve Gokcen Polat, Yasin Kalpakcı, Ali Zahit Bolaman, Birol Guvenc, Sehmus Ertop

Get full text

Do Alarmins Have a Role in Multiple Myeloma? by Ayfer Gedük, Merve Gökçen Polat, Esra Terzi Demirsoy, Berrin Öztaş, Baldan Huri Eryılmaz, Emel Merve Yenihayat, Hayrunnisa Albayrak, Haşim Atakan Erol, Özgür Mehtap, Pınar Tarkun, Abdullah Hacıhanefioğlu

Get full text